+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Buccal Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Buccal Tablets & Lozenges, Sublingual Films), By Application, By End-user, By Region, And Segment Forecasts, 2021 - 2028

  • PDF Icon

    Report

  • 135 Pages
  • November 2021
  • Region: Global
  • Grand View Research
  • ID: 5505329
The global buccal drug delivery systems market size is expected to reach USD 5.9 billion by 2028, according to a new report by the publisher. The market is expected to expand at a CAGR of 9.2% from 2021 to 2028. Buccal drug delivery systems have gained significant momentum since the last decade. Elimination of first-pass metabolism, quick absorption of the pH-sensitive drug, no interaction with stomach acid, quicker onset of action than any oral dose, minimal side effects, and reduced drug degradation are some of the factors fueling the market growth. Buccal drug delivery has gained large acceptance among geriatric patients and patients having difficulty swallowing.



Leading players like Generex, NovaDel, Biodiversity Sciences International, and Transcept Pharmaceuticals are constantly developing critical drugs like insulin, heparin, morphine, long-lasting pain analgesics, and some anti cardiac drugs into rapid mists, mucoadhesive discs, and lozenges. Commercialization of this research would eventually lead to being a major life savior as it would ensure the faster onset of action and eliminate drug degradation. Despite the increased R&D activity among market players, asteep decline was observed in the sales and revenue gainsdue to the outbreak of the Covid-19 pandemic. Except for covid medications, several other drug markets were majorly hit leading to the dip in the market for buccal drug delivery. However, it is expected to bounce back by 2022.

Buccal Drug Delivery Systems Market Report Highlights

  • The buccal tablets and lozenges type segment accounted for the largest revenue share in 2020 due to its wider acceptance among patients
  • The smoking cessation application segment held the largest share in 2020. Buccal drug delivery is often the most preferred and effective formulation for treating patients with smoking or nicotine addiction
  • The hospital end-user segment captured the largest revenue share in 2020 owing to a large number of admissions of geriatric patients and abundant medication supplies
  • North America held the largest revenue share in 2020 due to a large number of leading manufacturers and growing research in the region


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End User
1.1.4. Region
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. End-user outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Buccal drug delivery system Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Improved research in this field
3.4.1.2. Large number of market players
3.4.2. Market restraint analysis
3.4.2.1. Critical formulation process
3.5. Buccal drug delivery system Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies

Chapter 4. Buccal drug delivery system: Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Sublingual Films
4.1.2. Buccal Tablets and lozenges
4.1.3. Oral sprays
4.2. Buccal drug delivery system Market Share, 2021 & 2028
4.3. Segment Dashboard
4.4. Global Buccal drug delivery system Market by Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.5.1. Sublingual films
4.5.1.1. Sublingual film-based Market estimates and forecast 2016 to 2028 (USD Million)
4.5.2. Buccal Tablets and lozenges
4.5.2.1. Buccal Tablets and lozenges-based Market estimates and forecast 2016 to 2028 (USD Million)
4.5.3. Oral Sprays
4.5.3.1. Oral sprays-based Market estimates and forecast 2016 to 2028 (USD Million)

Chapter 5. Buccal drug delivery system: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Pain Management
5.1.2. Smoking Cessation
5.1.3. Angina Pectoris
5.1.4. Others
5.2. Buccal drug delivery system Market Share, 2021 & 2028
5.3. Segment Dashboard
5.4. Global Buccal drug delivery system Market by application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.5.1. Pain management
5.5.1.1. Pain management Market estimates and forecast 2016 to 2028 (USD Million)
5.5.2. Smoking Cessation
5.5.2.1. Smoking Cessation Market estimates and forecast 2016 to 2028 (USD Million)
5.5.3. Angina Pectoris
5.5.3.1. Angina Pectoris Market estimates and forecast 2016 to 2028 (USD Million)
5.5.4. Others
5.5.4.1. Others Market estimates and forecast 2016 to 2028 (USD Million)

Chapter 6. Buccal drug delivery system: End-user Estimates & Trend Analysis
6.1. Definitions and Scope
6.2. Hospitals
6.3. Ambulatory centers
6.4. Others
6.5. Buccal drug delivery system Market Share, 2021 & 2028
6.6. Segment Dashboard
6.7. Global Buccal drug delivery system Market by end-user Outlook
6.8. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
6.8.1. Hospitals
6.8.1.1. Pharmaceutical companies market estimates and forecast 2016 to 2028 (USD Million)
6.8.2. Ambulatory centers
6.8.2.1. Ambulatory centers market estimates and forecast 2016 to 2028 (USD Million)
6.8.3. Others
6.8.3.1. Others market estimates and forecast 2016 to 2028 (USD Million)

Chapter 7. Buccal drug delivery system Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2020 & 2028
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2020 & 2028:
7.7. North America
7.7.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8. Europe
7.8.1. U.K.
7.8.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.2. Germany
7.8.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.3. France
7.8.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.4. Italy
7.8.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.5. Spain
7.8.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.6. Norway
7.8.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.7. Sweden
7.8.7.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.8. Russia
7.8.8.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9. Asia Pacific
7.9.1. Japan
7.9.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9.2. China
7.9.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9.3. India
7.9.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9.4. Thailand
7.9.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9.5. South Korea
7.9.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9.6. Australia
7.9.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.10.2. Mexico
7.10.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.10.3. Argentina
7.10.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.11. MEA
7.11.1. South Africa
7.11.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.11.2. Saudi Arabia
7.11.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.11.4. Turkey
7.11.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2020
8.3.4. Teva Pharmaceutical Industries Ltd.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Pfizer Inc.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Glaxo Smith Klein
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Indivior Pharmaceuticals
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Catalent
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Generex Biotechnology
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Biodelivery Sciences International, Inc.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Endo Pharmaceuticals
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. ARx LLC
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Cynapsus Therapeutic Inc.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiativesList of Tables
Table 1 List of Abbreviation
Table 2 North America Buccal drug delivery system market, by country, 2016 - 2028 (USD Million)
Table 3 North America Buccal drug delivery system market, by type, 2016 - 2028 (USD Million)
Table 4 North America Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 5 North America Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 6 U.S. Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 7 U.S. Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 8 U.S. Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 9 Canada Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 10 Canada Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 11 Canada Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 12 Europe Buccal drug delivery system market, by country, 2016 - 2028 (USD Million)
Table 13 Europe Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 14 Europe Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 15 Europe Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 16 Germany Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 17 Germany Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 18 Germany Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 19 France Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 20 France Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 21 France Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 22 Italy Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 23 Italy Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 24 Italy Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 25 Spain Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 26 Spain Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 27 Spain a Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 28 U.K. Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 29 U.K. Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 30 U.K. Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 31 Norway Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 32 Norway Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 33 Norway Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 34 Sweden Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 35 Sweden Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 36 Sweden Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 37 Russia Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 38 Russia Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 39 Russia a Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 40 Asia Pacific Buccal drug delivery system market, by country, 2016 - 2028 (USD Million)
Table 41 Asia Pacific Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 42 Asia Pacific Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 43 Asia Pacific Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 44 Japan Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 45 Japan Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 46 Japan Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 47 China Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 48 China Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 49 China Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 50 India Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 51 India Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 52 India Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 53 Australia Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 54 Australia Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 55 Australia Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 56 South Korea Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 57 South Korea Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 58 South Korea Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 59 Thailand Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 60 Thailand Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 61 Thailand Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 62 Latin America Buccal drug delivery system market, by country, 2016 - 2028 (USD Million)
Table 63 Latin America Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 64 Latin America Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 65 Latin America Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 66 Mexico Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 67 Mexico Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 68 Mexico Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 69 Brazil Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 70 Brazil Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 71 Brazil Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 72 Argentina Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 73 Argentina Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 74 Argentina Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 75 Middle East and Africa Buccal drug delivery system market, by country, 2016 - 2028 (USD Million)
Table 76 Middle East and Africa Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 77 Middle East and Africa Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 78 Middle East and Africa Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 79 South Africa Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 80 South Africa Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 81 South Africa Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 82 Saudi Arabia Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 83 Saudi Arabia Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 84 Saudi Arabia Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 85 Turkey Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 86 Turkey Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 87 Turkey Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 88 UAE Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 89 UAE Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 90 UAE Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)

List of Figures
Figure. 1 Market research process
Figure. 2 Data triangulation techniques
Figure. 3 Primary research pattern
Figure. 4 Primary interviews in North America
Figure. 5 Primary interviews in Europe
Figure. 6 Primary interviews in APAC
Figure. 7 Primary interviews in Latin America
Figure. 8 Primary interviews in MEA
Figure. 9 Market research approaches
Figure. 10 Value-chain-based sizing & forecasting
Figure. 11 QFD modeling for market share assessment
Figure. 12 Market formulation & validation
Figure. 13 Buccal drug delivery system market: market outlook
Figure. 14 Buccal drug delivery system market competitive insights
Figure. 15 Parent market outlook
Figure. 16 Related/ancillary market outlook
Figure. 17 Penetration and growth prospect mapping
Figure. 18 Industry value chain analysis
Figure. 19 Buccal drug delivery system market driver impact
Figure. 20 Buccal drug delivery system market restraint impact
Figure. 21 Buccal drug delivery system market strategic initiatives analysis
Figure. 22 Buccal drug delivery system market: type movement analysis
Figure. 23 Buccal drug delivery system market: type outlook and key takeaways
Figure. 24 Sublingual films market estimates and forecast, 2016 - 2028
Figure. 25 Buccal Tablets and lozenges Based market estimates and forecast, 2016 - 2028
Figure. 26 Oral Sprays Based market estimates and forecast, 2016 - 2028
Figure. 27 Buccal drug delivery system market: application movement analysis
Figure. 28 Buccal drug delivery system market: application outlook and key takeaways
Figure. 29 Pain Management Market Estimates and Forecast, 2016 - 2028
Figure. 30 Smoking Cessation Market Estimates and Forecast, 2016 - 2028
Figure. 31 Angina Pectoris Market Estimates and Forecast, 2016 – 2028
Figure. 32 Others Estimates and Forecast, 2016 - 2028
Figure. 33 Buccal drug delivery system Market: End-user Analysis
Figure. 34 Buccal drug delivery system Market: End-user outlook and key takeaways
Figure. 35 Hospitals Market Estimates and Forecast, 2016 - 2028
Figure. 36 Ambulatory Centers Market Estimates and Forecast, 2016 - 2028
Figure. 37 Others Market Estimates and Forecast, 2016 – 2028
Figure. 38 Global Buccal drug delivery system market: regional movement analysis
Figure. 39 Global Buccal drug delivery system market: regional outlook and key takeaways
Figure. 40 Global market share and leading players
Figure. 41 North America market share and leading players
Figure. 42 Europe market share and leading players
Figure. 43 Asia Pacific market share and leading players
Figure. 44 Latin America market share and leading players
Figure. 45 Middle East & Africa market share and leading players
Figure. 46 North America: SWOT
Figure. 47 Europe SWOT
Figure. 48 Asia Pacific SWOT
Figure. 49 Latin America SWOT
Figure. 50 MEA SWOT
Figure. 51 North America, by country
Figure. 52 North America
Figure. 53 North America market estimates and forecast, 2016 - 2028
Figure. 54 U.S.
Figure. 55 U.S. market estimates and forecast, 2016 - 2028
Figure. 56 Canada
Figure. 57 Canada market estimates and forecast, 2016 - 2028
Figure. 58 Europe
Figure. 59 Europe market estimates and forecast, 2016 - 2028
Figure. 60 U.K.
Figure. 61 U.K. market estimates and forecast, 2016 - 2028
Figure. 62 Germany
Figure. 63 Germany market estimates and forecast, 2016 - 2028
Figure. 64 France
Figure. 65 France market estimates and forecast, 2016 - 2028
Figure. 66 Italy
Figure. 67 Italy market estimates and forecast, 2016 - 2028
Figure. 68 Spain
Figure. 69 Spain market estimates and forecast, 2016 - 2028
Figure. 70 Russia
Figure. 71 Russia market estimates and forecast, 2016 - 2028
Figure. 72 Sweden
Figure. 73 Sweden market estimates and forecast, 2016 - 2028
Figure. 74 Norway
Figure. 75 Norway market estimates and forecast, 2016 - 2028
Figure. 76 Asia Pacific
Figure. 77 Asia Pacific market estimates and forecast, 2016 - 2028
Figure. 78 China
Figure. 79 China market estimates and forecast, 2016 - 2028
Figure. 80 Japan
Figure. 81 Japan market estimates and forecast, 2016 - 2028
Figure. 82 India
Figure. 83 India market estimates and forecast, 2016 - 2028
Figure. 84 Thailand
Figure. 85 Thailand market estimates and forecast, 2016 - 2028
Figure. 86 South Korea
Figure. 87 South Korea market estimates and forecast, 2016 - 2028
Figure. 88 Australia
Figure. 89 Australia market estimates and forecast, 2016 - 2028
Figure. 90 Latin America
Figure. 91 Latin America market estimates and forecast, 2016 - 2028
Figure. 92 Brazil
Figure. 93 Brazil market estimates and forecast, 2016 - 2028
Figure. 94 Mexico
Figure. 95 Mexico market estimates and forecast, 2016 - 2028
Figure. 96 Argentina
Figure. 97 Argentina market estimates and forecast, 2016 - 2028
Figure. 98 Middle East and Africa
Figure. 99 Middle East and Africa market estimates and forecast, 2016 - 2028
Figure. 100 South Africa
Figure. 101 South Africa market estimates and forecast, 2016 - 2028
Figure. 102 Saudi Arabia
Figure. 103 Saudi Arabia market estimates and forecast, 2016 - 2028
Figure. 104 UAE
Figure. 105 UAE market estimates and forecast, 2016 - 2028
Figure. 106 Turkey
Figure. 107 Turkey market estimates and forecast, 2016 - 2028
Figure. 108 Participant categorization- Buccal drug delivery system market
Figure. 109 Market share of key market players- Buccal drug delivery system markets

Companies Mentioned

  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Glaxo Smith Klein
  • Indivior Pharmaceuticals
  • Catalent
  • Generex Biotechnology
  • Biodelivery Sciences International, Inc.
  • Endo Pharmaceuticals
  • ARx LLC
  • Cynapsus Therapeutic Inc.

Methodology

Loading
LOADING...

Table Information